Immunome, Inc.IMNMNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-305.80M
↓ 322% below average
Average (6y)
$-72.54M
Historical baseline
Range
High:$-7.74M
Low:$-305.80M
CAGR
+84.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-305.80M | -179.2% |
| 2023 | $-109.53M | -196.8% |
| 2022 | $-36.90M | -46.4% |
| 2021 | $-25.20M | -105.6% |
| 2020 | $-12.26M | -18.5% |
| 2019 | $-10.35M | -33.6% |
| 2018 | $-7.74M | - |